-
New systemic treatment paradigms in resectable non-small cell lung cancer and variations in patient access across Europe
Houda, I., Dickhoff, C., Uyl-de Groot, C. A., Reguart, N., Provencio, M., Levy, A., Dziadziuszko, R., Pompili, C., Di Maio, M., Thomas, M., Brunelli, A., Popat, S., Senan, S. & Bahce, I., Mar 2024, In: The Lancet Regional Health - Europe. 38, p. 100840 100840.Research output: Contribution to journal › Review article › Academic › peer-review
-
Predictive Value of Combined Positive Score and Tumor Proportion Score for Immunotherapy Response in Advanced NSCLC
Ulas, E. B., Hashemi, S. M. S., Houda, I., Kaynak, A., Veltman, J. D., Fransen, M. F., Radonic, T. & Bahce, I., 1 Sept 2023, In: JTO Clinical and Research Reports. 4, 9, 100532.Research output: Contribution to journal › Article › Academic › peer-review
-
The effect of tumor size and metastatic extent on the efficacy of first line pembrolizumab monotherapy in patients with high PD-L1 expressing advanced NSCLC tumors
Schakenraad, A., Hashemi, S. M. S., Twisk, J. W. R., Houda, I., Ulas, E. B., Daniels, J. M. A., Veltman, J. D. & Bahce, I., 5 Oct 2021, In: Lung Cancer. 162, p. 36-41 6 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
